Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1270385

Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort


Kissling, Esther; Pozo, Francisco; Buda, Silke; Vilcu, Ana-Maria; Gherasim, Alin; Brytting, Mia; Domegan, Lisa; Gómez, Verónica; Meijer, Adam; Lazar, Mihaela et al.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort // Eurosurveillance, 24 (2019), 48; 1900604, 12 doi:10.2807/1560-7917.es.2019.24.48.1900604 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1270385 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort

Autori
Kissling, Esther ; Pozo, Francisco ; Buda, Silke ; Vilcu, Ana-Maria ; Gherasim, Alin ; Brytting, Mia ; Domegan, Lisa ; Gómez, Verónica ; Meijer, Adam ; Lazar, Mihaela ; Vučina, Vesna Višekruna ; Dürrwald, Ralf ; van der Werf, Sylvie ; Larrauri, Amparo ; Enkirch, Theresa ; O’Donnell, Joan ; Guiomar, Raquel ; Hooiveld, Mariëtte ; Petrović, Goranka ; Stoian, Elena ; Penttinen, Pasi ; Valenciano, Marta ; I-MOVE primary care study team

Izvornik
Eurosurveillance (1560-7917) 24 (2019), 48; 1900604, 12

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
influenza vaccination, test negative case control, vaccine effectiveness

Sažetak
Introduction Influenza A(H3N2) clades 3C.2a and 3C.3a co-circulated in Europe in 2018/19. Immunological imprinting by first childhood influenza infection may induce future birth cohort differences in vaccine effectiveness (VE). Aim The I-MOVE multicentre primary care test-negative study assessed 2018/19 influenza A(H3N2) VE by age and genetic subgroups to explore VE by birth cohort. Methods We measured VE against influenza A(H3N2) and (sub)clades. We stratified VE by usual age groups (0–14, 15–64, ≥ 65-years). To assess the imprint-regulated effect of vaccine (I-REV) hypothesis, we further stratified the middle-aged group, notably including 32–54-year-olds (1964–86) sharing potential childhood imprinting to serine at haemagglutinin position 159. Results Influenza A(H3N2) VE among all ages was −1% (95% confidence interval (CI): −24 to 18) and 46% (95% CI: 8–68), −26% (95% CI: −66 to 4) and 20% (95% CI: −20 to 46) among 0–14, 15–64 and ≥ 65-year-olds, respectively. Among 15–64-year-olds, VE against clades 3C.2a1b and 3C.3a was 15% (95% CI: −34 to 50) and −74% (95% CI: −259 to 16), respectively. VE was −18% (95% CI: −140 to 41), −53% (95% CI: −131 to −2) and −12% (95% CI: −74 to 28) among 15–31-year-olds (1987–2003), 32–54-year-olds (1964–86) and 55–64-year-olds (1954–63), respectively. Discussion The lowest 2018/19 influenza A(H3N2) VE was against clade 3C.3a and among those born 1964–86, corresponding to the I-REV hypothesis. The low influenza A(H3N2) VE in 15–64-year-olds and the public health impact of the I-REV hypothesis warrant further study.

Izvorni jezik
Engleski

Znanstvena područja
Javno zdravstvo i zdravstvena zaštita



POVEZANOST RADA


Ustanove:
Hrvatski zavod za javno zdravstvo

Poveznice na cjeloviti tekst rada:

doi

Citiraj ovu publikaciju:

Kissling, Esther; Pozo, Francisco; Buda, Silke; Vilcu, Ana-Maria; Gherasim, Alin; Brytting, Mia; Domegan, Lisa; Gómez, Verónica; Meijer, Adam; Lazar, Mihaela et al.
Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort // Eurosurveillance, 24 (2019), 48; 1900604, 12 doi:10.2807/1560-7917.es.2019.24.48.1900604 (međunarodna recenzija, članak, znanstveni)
Kissling, E., Pozo, F., Buda, S., Vilcu, A., Gherasim, A., Brytting, M., Domegan, L., Gómez, V., Meijer, A. & Lazar, M. (2019) Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort. Eurosurveillance, 24 (48), 1900604, 12 doi:10.2807/1560-7917.es.2019.24.48.1900604.
@article{article, author = {Kissling, Esther and Pozo, Francisco and Buda, Silke and Vilcu, Ana-Maria and Gherasim, Alin and Brytting, Mia and Domegan, Lisa and G\'{o}mez, Ver\'{o}nica and Meijer, Adam and Lazar, Mihaela and Vu\v{c}ina, Vesna Vi\v{s}ekruna and D\"{u}rrwald, Ralf and van der Werf, Sylvie and Larrauri, Amparo and Enkirch, Theresa and O’Donnell, Joan and Guiomar, Raquel and Hooiveld, Mari\"{e}tte and Petrovi\'{c}, Goranka and Stoian, Elena and Penttinen, Pasi and Valenciano, Marta}, year = {2019}, pages = {12}, DOI = {10.2807/1560-7917.es.2019.24.48.1900604}, chapter = {1900604}, keywords = {influenza vaccination, test negative case control, vaccine effectiveness}, journal = {Eurosurveillance}, doi = {10.2807/1560-7917.es.2019.24.48.1900604}, volume = {24}, number = {48}, issn = {1560-7917}, title = {Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort}, keyword = {influenza vaccination, test negative case control, vaccine effectiveness}, chapternumber = {1900604} }
@article{article, author = {Kissling, Esther and Pozo, Francisco and Buda, Silke and Vilcu, Ana-Maria and Gherasim, Alin and Brytting, Mia and Domegan, Lisa and G\'{o}mez, Ver\'{o}nica and Meijer, Adam and Lazar, Mihaela and Vu\v{c}ina, Vesna Vi\v{s}ekruna and D\"{u}rrwald, Ralf and van der Werf, Sylvie and Larrauri, Amparo and Enkirch, Theresa and O’Donnell, Joan and Guiomar, Raquel and Hooiveld, Mari\"{e}tte and Petrovi\'{c}, Goranka and Stoian, Elena and Penttinen, Pasi and Valenciano, Marta}, year = {2019}, pages = {12}, DOI = {10.2807/1560-7917.es.2019.24.48.1900604}, chapter = {1900604}, keywords = {influenza vaccination, test negative case control, vaccine effectiveness}, journal = {Eurosurveillance}, doi = {10.2807/1560-7917.es.2019.24.48.1900604}, volume = {24}, number = {48}, issn = {1560-7917}, title = {Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort}, keyword = {influenza vaccination, test negative case control, vaccine effectiveness}, chapternumber = {1900604} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font